So? This has nothing to do with that.
—-what I’m referring to is where in the treatment guidelines or practices this dimx drug will fit because there are a number of immunological drugs already used first line (check this out
https://kdigo.org/wp-content/uploads/2022/12/How-I-Treat-FSGS.pdf
—- this dimx drug looks a comparatively weaker immunological drug compared with the powerful drugs already used, I don’t see it replacing established things referenced in the article like steroids or calcineurim inhib, rituximab.
—— dimx drug looks like it’s v safe, but lack of side effects is probably an indication of its weaker immunological ability.
—-/ looks more like a back up reserve drug to use once you’ve exhausted other things
Ann: Dimerix Completes $20M Placement, page-88
-
- There are more pages in this discussion • 66 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
61.0¢ |
Change
0.055(9.91%) |
Mkt cap ! $335.3M | |||
| Open | High | Low | Value | Volume |
| 57.0¢ | 61.5¢ | 56.5¢ | $1.938M | 3.305M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3652 | 60.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 61.0¢ | 27035 | 1 |
View Market Depth
| Last trade - 16.10pm 20/06/2024 (20 minute delay) ? |
| DXB (ASX) Chart |